When a water main broke at 5 a.m. and released over 1,000,000 gallons of water, flooding multiple hospital buildings, Crothall’s dedicated EVS team jumped into action. The flooding occurred at Allegheny General Hospital in Pittsburgh on Dec. 4, 2024 But thanks to 12 Crothall EVS floor technicians, the hospital continued to operate as usual, only…
Caris Life Sciences applies AI and machine learning to patient samples to detect cancer and as a companion diagnostic guiding the use of targeted cancer therapies. As a commercial-stage company, Caris’s upsized public markets debut is an outlier amid the continuing IPO freeze for clinical-stage biotechs developing new drugs. The post Precision Medicine Firm Caris…
Founded in 2014, the company, which helps over 2,500 primary care physicians across 36 states, achieved the top ranking with $1.5 billion in revenue for 2023
A planned interim clinical trial analysis found Praxis Precision Medicines drug ulixacaltamide was unlikely to succeed as a treatment for essential tremor. But Praxis is continuing two late-stage tests of the drug; data are expected in the third quarter of 2025. The post Praxis Presses Forward in Essential Tremor Despite Futility Finding From Trial Observers…
Employers are prioritizing mental wellbeing programs, but employees say they need financial wellbeing support, according to a survey from WTW. The post WTW: There’s A Disconnect Between Employers and Employees on Wellbeing Programs appeared first on MedCity News.
Panelists at a covid conference last fall were asked to voice their regrets — policies they had supported during the pandemic but had come to see as misguided. Covid contact tracing, one said. Closing schools, another said. Vaccine mandates, a third said. When Marty Makary’s turn came, the Johns Hopkins University surgeon said, “I can’t…
To deal with rising costs, employers are leveraging high performance networks, variable copay plans and exclusive provider organization plans. The post Rising Healthcare Costs: What Employers Are Doing to Manage Expenses, Per Mercer appeared first on MedCity News.
Waskyra is the first FDA-approved gene therapy for the rare disease Wiskott-Aldrich syndrome and the first such approved product from a non-profit applicant, Fondazione Telethon. Data from Waskyra’s pivotal studies were presented this week during the annual meeting of the American Society of Hematology. The post FDA Flexibility Leads to First Approved Gene Therapy for…
Health system performance has splintered into three distinct groups — leaders, strugglers and those stuck in the middle, according to Fitch Ratings’ Kevin Holloran. At the HFMA Annual Conference, he and Mayo Clinic CFO Dennis Dahlen discussed how technology and innovation are accelerating this divide. The post The Hospital Word Has Become a Tale of…
This policy watch examines the June 18 Supreme Court ruling upholding a Tennessee ban on gender-affirming care for transgender youth in the case of the United States v. Skrmetti, how it will affect access in other states with similar bans, and other implications.